Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Aging Neurosci., 29 January 2026

Sec. Neurocognitive Aging and Behavior

Volume 18 - 2026 | https://doi.org/10.3389/fnagi.2026.1744201

Correction: Choline alphoscerate: insights between acquired certainties and future perspectives

This article is a correction to:

  1. Choline alphoscerate: insights between acquired certainties and future perspectives

    1. Read original article
Giovanni Biggio, Giovanni Biggio1,2*Claudio Mencacci Claudio Mencacci3*
  • 1Department of Life and Environmental Sciences, University of Cagliari, Cittadella Universitaria di Monserrato, Cagliari, Italy
  • 2Institute of Neuroscience, CNR, Cittadella Universitaria di Monserrato, Cagliari, Italy
  • 3Department of Neuroscience and Mental Health, ASST Fatebenefratelli Sacco, Milan, Italy
Graphical Abstract
Diagram illustrating the effects of choline alphoscerate on the brain. It highlights benefits like enhancement of cognitive functions and synaptic signaling. Key aspects include epigenetic regulation, acetylcholine neurotransmission, and membrane lipid composition. The diagram shows interactions with enzymes and neurotransmitters in the synaptic cleft, and includes references to Alzheimer's disease and healthy aging. Various compounds and neurotransmitters like acetylcholine, SAM, and Co-A are labeled, with processes such as the modulation of gene expression and enhancement of cholinergic tone noted. The image includes a legend for anti-cholinesterases.

Graphical Abstract

A Correction on
Choline alphoscerate: insights between acquired certainties and future perspectives

by Biggio, G., and Mencacci, C. (2025). Front. Aging Neurosci. 17:1613566. doi: 10.3389/fnagi.2025.1613566

The graphical abstract of the published article was erroneously omitted. The graphical abstract appears below.

The original version of this article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: aging, choline alphoscerate, cognitive dysfunction, mild cognitive impairment, sleep disorders

Citation: Biggio G and Mencacci C (2026) Correction: Choline alphoscerate: insights between acquired certainties and future perspectives. Front. Aging Neurosci. 18:1744201. doi: 10.3389/fnagi.2026.1744201

Received: 11 November 2025; Revised: 30 December 2025; Accepted: 12 January 2026;
Published: 29 January 2026.

Edited and reviewed by: R. M. Damian Holsinger, The University of Sydney, Australia

Copyright © 2026 Biggio and Mencacci. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Giovanni Biggio, Z2lvdmFubmkuYmlnZ2lvQGxpYmVyby5pdA==; YmlnZ2lvQHVuaWNhLml0; Claudio Mencacci, Y2xhdWRpby5tZW5jYWNjaUBnbWFpbC5jb20=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.